ArticleFrontiers in immunology2022

Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells.

Julia Hambach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.